IM Cannabis (IMCC) Income from Continuing Operations (2020 - 2026)
IM Cannabis (IMCC) recorded quarterly Income from Continuing Operations of 1858745.31 in Q1 2026, up 67.05% quarter-over-quarter from 5640600.7 in Q4 2025, and down 2379.57% on a YoY basis from 81539.23 in Q1 2025.
IM Cannabis (IMCC) Income from Continuing Operations (2020 - 2026) Analysis & Trends
IM Cannabis' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 1858745.31 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 2379.57% year-over-year to 1858745.31; the TTM figure through Mar 2026 stood at 10447802.52 (down 154.4% YoY), while the FY2025 annual figure was 8425763.83, up 2.0% from the prior year.
- Income from Continuing Operations was 1858745.31 for Q1 2026 at IM Cannabis, up from 5640600.7 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3162061.52 in Q3 2022 to a low of 31126435.92 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 4111260.74 across 5 years, with a median of 2526821.73 in 2024.
- The sharpest annual moves came in 2022 and 2026: Income from Continuing Operations surged 379.57% in 2022, then slumped 2379.57% in 2026.
- A 5-year view of Income from Continuing Operations shows it stood at 31126435.92 in 2022, then surged by 60.03% to 12440093.69 in 2023, then soared by 93.02% to 868325.01 in 2024, then tumbled by 549.6% to 5640600.7 in 2025, then surged by 67.05% to 1858745.31 in 2026.
- The last three Income from Continuing Operations figures came in at 1858745.31 (Q1 2026), 5640600.7 (Q4 2025), and 2808444.29 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | -1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.86 Mn |
| Dec 31, 2025 | -5.64 Mn |
| Sep 30, 2025 | -2.81 Mn |
| Jun 30, 2025 | -140,012.22 |
| Mar 31, 2025 | 81,539.23 |
| Dec 31, 2024 | -868,325.01 |
| Sep 30, 2024 | -793,163.79 |
| Jun 30, 2024 | -2.53 Mn |
| Mar 31, 2024 | -4.63 Mn |
| Dec 31, 2023 | -12.44 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | -2.76 Mn |
| Mar 31, 2023 | -640,577.05 |
| Dec 31, 2022 | -31.13 Mn |
| Sep 30, 2022 | 3.16 Mn |
| Jun 30, 2022 | -2.90 Mn |
| Mar 31, 2022 | -5.59 Mn |
| Dec 31, 2021 | -6.63 Mn |
| Sep 30, 2021 | 659,359.73 |
| Jun 30, 2021 | -4.14 Mn |